Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients

The pandemic of COVID-19 caused by SARS-CoV-2 infection continues to spread around the world. Vaccines that elicit protective immunity have reduced infection and mortality, however new viral variants are arising that may evade vaccine-induced immunity or cause disease in individuals who are unable t...

Full description

Bibliographic Details
Main Authors: Xufang Deng, Monika Evdokimova, Amornrat O’Brien, Cynthia L. Rowe, Nina M. Clark, Amanda Harrington, Gail E. Reid, Susan L. Uprichard, Susan C. Baker
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/9/1743
_version_ 1797516979689488384
author Xufang Deng
Monika Evdokimova
Amornrat O’Brien
Cynthia L. Rowe
Nina M. Clark
Amanda Harrington
Gail E. Reid
Susan L. Uprichard
Susan C. Baker
author_facet Xufang Deng
Monika Evdokimova
Amornrat O’Brien
Cynthia L. Rowe
Nina M. Clark
Amanda Harrington
Gail E. Reid
Susan L. Uprichard
Susan C. Baker
author_sort Xufang Deng
collection DOAJ
description The pandemic of COVID-19 caused by SARS-CoV-2 infection continues to spread around the world. Vaccines that elicit protective immunity have reduced infection and mortality, however new viral variants are arising that may evade vaccine-induced immunity or cause disease in individuals who are unable to develop robust vaccine-induced responses. Investigating the role of viral variants in causing severe disease, evading vaccine-elicited immunity, and infecting vulnerable individuals is important for developing strategies to control the pandemic. Here, we report fourteen breakthrough infections of SARS-CoV-2 in vaccinated individuals with symptoms ranging from asymptomatic/mild (6/14) to severe disease (8/14). High viral loads with a median C<i>t</i> value of 19.6 were detected in the nasopharyngeal specimens from subjects regardless of disease severity. Sequence analysis revealed four distinct virus lineages, including <i>alpha</i> and <i>gamma</i> variants of concern. Immunosuppressed individuals were more likely to be hospitalized after infection (<i>p</i> = 0.047), however no specific variant was associated with severe disease. Our results highlight the high viral load that can occur in asymptomatic breakthrough infections and the vulnerability of immunosuppressed individuals to post-vaccination infections by diverse variants of SARS-CoV-2.
first_indexed 2024-03-10T07:08:26Z
format Article
id doaj.art-2c50f784e26d47099389b1e0c6851881
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T07:08:26Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-2c50f784e26d47099389b1e0c68518812023-11-22T15:37:19ZengMDPI AGViruses1999-49152021-09-01139174310.3390/v13091743Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed PatientsXufang Deng0Monika Evdokimova1Amornrat O’Brien2Cynthia L. Rowe3Nina M. Clark4Amanda Harrington5Gail E. Reid6Susan L. Uprichard7Susan C. Baker8Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Medicine, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USAInfectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Medicine, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USADepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USAThe pandemic of COVID-19 caused by SARS-CoV-2 infection continues to spread around the world. Vaccines that elicit protective immunity have reduced infection and mortality, however new viral variants are arising that may evade vaccine-induced immunity or cause disease in individuals who are unable to develop robust vaccine-induced responses. Investigating the role of viral variants in causing severe disease, evading vaccine-elicited immunity, and infecting vulnerable individuals is important for developing strategies to control the pandemic. Here, we report fourteen breakthrough infections of SARS-CoV-2 in vaccinated individuals with symptoms ranging from asymptomatic/mild (6/14) to severe disease (8/14). High viral loads with a median C<i>t</i> value of 19.6 were detected in the nasopharyngeal specimens from subjects regardless of disease severity. Sequence analysis revealed four distinct virus lineages, including <i>alpha</i> and <i>gamma</i> variants of concern. Immunosuppressed individuals were more likely to be hospitalized after infection (<i>p</i> = 0.047), however no specific variant was associated with severe disease. Our results highlight the high viral load that can occur in asymptomatic breakthrough infections and the vulnerability of immunosuppressed individuals to post-vaccination infections by diverse variants of SARS-CoV-2.https://www.mdpi.com/1999-4915/13/9/1743SARS-CoV-2variants of concernbreakthrough infectionspost-vaccination infectionsCOVID-19immunosuppression
spellingShingle Xufang Deng
Monika Evdokimova
Amornrat O’Brien
Cynthia L. Rowe
Nina M. Clark
Amanda Harrington
Gail E. Reid
Susan L. Uprichard
Susan C. Baker
Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
Viruses
SARS-CoV-2
variants of concern
breakthrough infections
post-vaccination infections
COVID-19
immunosuppression
title Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
title_full Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
title_fullStr Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
title_full_unstemmed Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
title_short Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
title_sort breakthrough infections with multiple lineages of sars cov 2 variants reveals continued risk of severe disease in immunosuppressed patients
topic SARS-CoV-2
variants of concern
breakthrough infections
post-vaccination infections
COVID-19
immunosuppression
url https://www.mdpi.com/1999-4915/13/9/1743
work_keys_str_mv AT xufangdeng breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT monikaevdokimova breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT amornratobrien breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT cynthialrowe breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT ninamclark breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT amandaharrington breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT gailereid breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT susanluprichard breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients
AT susancbaker breakthroughinfectionswithmultiplelineagesofsarscov2variantsrevealscontinuedriskofseverediseaseinimmunosuppressedpatients